Since BRAF and NRAS mutations were found to be mutually exclusive (further confirming previous data[23]), a high prevalence of such alterations was observed in our series, with about two thirds of melanomas presenting a BRAF/NRAS mutation. The gene discussed is BRAF; the disease is melanoma.